Navigation Links
Kuvan Receives Priority Review Status From Health Canada
Date:6/10/2009

NOVATO, Calif., June 10 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received notice of priority review status for Kuvan(R) (sapropterin dihydrochloride) as an oral treatment for patients with phenylketonuria (PKU) from Health Canada. Priority review provides for a shortened submission review of 180 days versus the standard twelve months. BioMarin plans to file a marketing application for Kuvan in Canada in the third quarter of 2009, and with priority review status, a decision for marketing approval is expected in the first half of 2010.

"Priority review status from Health Canada marks another milestone in our efforts to commercialize Kuvan worldwide as it is granted for serious, life-threatening or severely debilitating diseases for which no approved medical therapy exists in Canada," said Steve Aselage, Senior Vice President and Chief Business Officer of BioMarin. "Along with our partners Merck Serono and Asubio, we remain dedicated to serving the PKU community and providing a therapeutic option in the management of this disease."

About Kuvan

Kuvan(R) (sapropterin dihydrochloride) Tablets are indicated in the United States to reduce blood phenylalanine (Phe) levels in patients with hyperphenylalaninemia (HPA) due to tetrahydrobiopterin- (BH4-) responsive phenylketonuria (PKU). Kuvan is to be used in conjunction with a Phe-restricted diet.

The active ingredient in Kuvan, sapropterin dihydrochloride, is the synthetic form of 6R-BH4 (tetrahydrobiopterin), a naturally occurring enzyme cofactor that works in conjunction with phenylalanine hydroxylase (PAH) to metabolize Phe.

Kuvan has received orphan drug designation from both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). Kuvan ha
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan
2. Kuvan, Naglazyme and Aldurazyme Data to Be Presented at the 57th Annual Meeting of the American Society of Human Genetics
3. Kuvan Receives Positive Opinion From CHMP for European Approval
4. Kuvan Receives Marketing Approval in the European Union
5. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
6. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
7. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
10. IsoTis Receives FDA Clearance for Accell Family of Products
11. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...LE, Nov. 20 Cell Therape... today that the Ninth Circuit Court of Appeals rev...TI should be allowed to pursue all of its claims a...e District Court for trial. CTI filed a complaint...reimbursement consultant for CTI,s product TRISENO...
(Date:11/19/2009)..., Nov. 19 Danish Prince Joachim in...thanol plant in Kalundborg, Denmark, on Wednesday,...irst and largest 2nd generation ethanol demonstrat...are used in the plant,s innovative process for con...isco, was the first to market with commercial enzy...
(Date:11/19/2009)... Nov. 19 NeoStem, Inc. (...t the following letter to its shareholders, discus...9, of China Biopharmaceuticals Holdings, Inc. (CHB... in the People,s Republic of China. The merger giv...re Pharmaceutical Co. Ltd., CHBP,s primary operati...
(Date:11/19/2009)... Nov. 19 /PRNewswire/ - Aegera Therapeutics Inc. a...a randomized Phase 2B study of AEG35156, a targete...or multiple oncology indications. ,, The study,...of the X-Linked Inhibitor of Apoptosis (XIAP) Anti... Cytarabine and Idarubicin in AML Following Failur...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...re, Inc., formerly known as Automating Peripherals...f the company. API Software, Inc. is a provider ...ll, human resources, productivity management, educ...lthcare organizations. , ,"After 20 years of evol...ustry as Automating Peripherals, Inc., we decided ...
...st six months of operation, the University of Wisc...experienced business and community-related success...or John Wiley , who charged it with serving the ne... door" to make the resources of the university mor...omplishments include interfacing with over 300 com...
...sume duties as director of the state Department o...Secretary Cory Nettles announced the hire last w...tive. , ,Part of the key to our successful entrep...lly lie in collaborative efforts. We hope to conne...n starting technology businesses to the right peop...
Other Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2
(Date:11/19/2009)...TE, Ind. - Purdue University scientists have helpe...nsible for cell wall development in maize, an effo...produce the biomass best suited for biofuels produ...Carpita, a professor of plant cell biology, publis...he journal Plant Physiology on Thursday (Nov. 19...
(Date:11/19/2009)... November 19, 2009 A team led by scientists at Th...ect link between insulina hormone long associated ...abetesand core body temperature. While much resear...ry in the 1920s, this is the first time the hormon... temperature regulation. , The paper was publish...
(Date:11/19/2009)..., Md.-John Fisher, associate professor in the Fisc...ventor Pitch at the 2009 Bioscience Research and T...reactor system that grows bone and other types of ...as one of six innovations presented in an eight mi...s at the Professor Venture Fair, held November 12 ...
Breaking Biology News(10 mins):Maize cell wall genes identified, giving boost to biofuel research 2Scripps research scientists find new link between insulin and core body temperature 2Scripps research scientists find new link between insulin and core body temperature 3Scripps research scientists find new link between insulin and core body temperature 4Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Scientists uncork a potential secret of red wines health benefits 9432 1Scientists uncork a potential secret of red wines health benefits 9432 2Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 1Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 2Leicester research paves way for first use in Europe of an insect to fight invasive plant 9429 3China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 1China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 2China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 3China Medical Technologies Announces the Substantial Completion of an Independent Internal Investigation and Expected Timing of Reporting of Unaudited 53242 4
...ER 30, 2008)The Bronx Zoo-based Wildlife Conservat...otect a wildlife-rich coastal region in South Amer...ine park recently signed into law by the Governmen...ame official earlier this month, protects half a m... seabirds and the region,s only population of Sout...
...t The Ohio State University Comprehensive Cancer C...n leukemia and lung cancer is also important in mu...inly children. , The study shows that immature m...o become mature, and that the molecule is nearly m...used by the proliferation of immature muscle cells...
...rradiation , Researchers led by Dr. Batrice Cous...n damages fat tissue. They report their findings i...of Pathology . , Radiation therapy directed at ...ologous transplant of tissues such as fat tissue h...dysfunction, and necrosis that result from radiati...
Other Biology News:A happy new year for penguins 2Study links molecule to muscle maturation, muscle cancer 2Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 5
Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
... at the 3, 3', 4, and 4' positions. It is intended...ation of Prostaglandin E2 (PGE2) by GC- or LC-mass...genase products of arachidonic acid and one of the...vity influences inflammation, fertility and partur...
Agarose Gel Loading Dye Mixture 6X (with ficoll) from GenScript Corporation
Site-directed Mutagenesis from Exon BioSystems
Biology Products: